{
  "@context": "aku-v2",
  "@type": "definition",
  "@id": "wsmg:health-sciences/medicine/neurology/neuro-018",
  "metadata": {
    "version": "4.0.0",
    "created": "2026-01-09T01:54:58.000Z",
    "modified": "2026-01-13T14:42:00.000Z",
    "contributors": [
      "copilot-agent",
      "quality-enhancement-agent",
      "quality-agent"
    ],
    "confidence": 0.96,
    "status": "validated",
    "language": "en",
    "licenses": ["CC-BY-4.0"]
  },
  "classification": {
    "domain_path": "health-sciences/medicine/neurology",
    "subdomain": "neurodegenerative_disorders",
    "type": "definition",
    "difficulty": "advanced",
    "importance": "high",
    "isNativeDomain": true,
    "board_yield": "MEDIUM"
  },
  "content": {
    "title": "Frontotemporal Dementia",
    "summary": "Frontotemporal dementia (FTD) is a clinically and pathologically heterogeneous group of neurodegenerative disorders primarily affecting the frontal and temporal lobes, characterized by progressive changes in behavior, personality, and/or language, typically with younger onset (45-65 years) and relative sparing of memory early in the disease course.",
    "key_points": [
      "Second most common cause of early-onset dementia (after Alzheimer's)",
      "Three main clinical variants: behavioral (bvFTD), semantic (svPPA), nonfluent (nfvPPA)",
      "bvFTD: disinhibition, apathy, loss of empathy, compulsive behaviors",
      "Memory relatively preserved early; personality/behavior changes predominate",
      "30-50% have genetic cause (C9orf72, MAPT, GRN mutations)",
      "MRI shows focal frontal and/or temporal atrophy; 'knife-edge' gyri"
    ],
    "statement": "Frontotemporal dementia is a neurodegenerative syndrome characterized by progressive deterioration of behavior, personality, and/or language due to selective frontal and temporal lobe degeneration, with typically younger onset and initial preservation of episodic memory.",
    "explanation": {
      "intuition": "While Alzheimer's attacks memory first, FTD attacks the parts of the brain that make us 'who we are' - our personality, social behavior, and language. A patient with FTD might forget social rules, act inappropriately, or lose the meaning of words, while still remembering their grandchildren's names.",
      "key_insight": "The three clinical variants reflect different anatomical patterns: behavioral variant (frontal lobe) causes disinhibition and apathy; semantic variant (anterior temporal) causes loss of word/object meaning; nonfluent variant (left perisylvian) causes effortful, agrammatic speech.",
      "technical_details": "FTD pathology is classified as FTLD-tau (4R or 3R tauopathies including Pick's disease, PSP, CBD), FTLD-TDP (types A-E), or FTLD-FUS. C9orf72 hexanucleotide repeat expansion is the most common genetic cause and can present with FTD, ALS, or both."
    },
    "definitions_glossary": {
      "frontotemporal_dementia": "Clinical syndrome of frontal/temporal neurodegeneration causing behavior/language changes",
      "behavioral_variant_FTD": "bvFTD; characterized by personality changes, disinhibition, apathy",
      "semantic_variant_PPA": "svPPA; progressive loss of word and object meaning with fluent empty speech",
      "nonfluent_variant_PPA": "nfvPPA; effortful, agrammatic speech with intact comprehension",
      "primary_progressive_aphasia": "PPA; progressive language disorder with three subtypes",
      "disinhibition": "Loss of normal social restraint; inappropriate behavior",
      "executive_dysfunction": "Impaired planning, judgment, organization from frontal lobe damage",
      "C9orf72": "Gene with hexanucleotide repeat expansion causing FTD and/or ALS",
      "MAPT": "Microtubule-associated protein tau gene; mutations cause tau-related FTD",
      "GRN": "Progranulin gene; mutations cause TDP-43 pathology FTD",
      "Pick_bodies": "Spherical tau inclusions characteristic of Pick's disease",
      "FTLD": "Frontotemporal lobar degeneration; pathological term for FTD",
      "knife_edge_atrophy": "Severe focal gyral atrophy seen on MRI in FTD"
    }
  },
  "clinical_features": {
    "pathophysiology": {
      "mechanism": "Selective neurodegeneration of frontal and temporal cortices with protein aggregation",
      "pathological_subtypes": {
        "FTLD_tau": {
          "subtypes": ["Pick's disease (3R tau)", "PSP (4R tau)", "CBD (4R tau)"],
          "genetics": "MAPT mutations"
        },
        "FTLD_TDP43": {
          "prevalence": "~50% of FTLD",
          "subtypes": ["Type A (GRN mutations)", "Type B (C9orf72)", "Type C (semantic variant)"],
          "genetics": "GRN, C9orf72, TBK1"
        },
        "FTLD_FUS": {
          "features": "Typically sporadic, younger onset, neuronal intermediate filament inclusions"
        }
      },
      "genetics": {
        "prevalence": "30-50% familial",
        "genes": {
          "C9orf72": "Most common; hexanucleotide repeat expansion; FTD + ALS spectrum",
          "MAPT": "Second most common; tau mutations",
          "GRN": "Progranulin haploinsufficiency"
        }
      }
    },
    "diagnostic_criteria": {
      "behavioral_variant_FTD": {
        "possible_bvFTD": "â‰¥3 of 6 behavioral features",
        "behavioral_features": [
          "Early behavioral disinhibition",
          "Early apathy or inertia",
          "Early loss of sympathy or empathy",
          "Early perseverative/compulsive/ritualistic behavior",
          "Hyperorality and dietary changes",
          "Executive/generation deficits with relative sparing of memory and visuospatial"
        ],
        "probable_bvFTD": "Possible + functional decline + imaging/pathology consistent"
      },
      "semantic_variant_PPA": {
        "core_features": [
          "Impaired confrontation naming",
          "Impaired single-word comprehension"
        ],
        "supportive_features": [
          "Impaired object knowledge",
          "Surface dyslexia/dysgraphia",
          "Spared repetition",
          "Spared grammar and motor speech"
        ]
      },
      "nonfluent_variant_PPA": {
        "core_features": [
          "Agrammatism in language production",
          "Effortful, halting speech (apraxia of speech)"
        ],
        "supportive_features": [
          "Impaired comprehension of complex sentences",
          "Spared single-word comprehension",
          "Spared object knowledge"
        ]
      },
      "imaging": {
        "MRI": "Focal frontal and/or temporal atrophy; knife-edge gyri",
        "patterns": {
          "bvFTD": "Bilateral frontal > temporal atrophy",
          "svPPA": "Anterior temporal atrophy (often L > R)",
          "nfvPPA": "Left perisylvian/insular atrophy"
        },
        "FDG_PET": "Hypometabolism in affected regions"
      }
    },
    "differential_diagnosis": [
      "Alzheimer's disease (memory predominant, older onset)",
      "Psychiatric disorders (depression, late-onset bipolar, schizophrenia)",
      "Primary psychiatric disorders mimicking bvFTD",
      "Progressive supranuclear palsy and corticobasal syndrome (overlap with FTD)",
      "Vascular dementia"
    ],
    "treatment_options": {
      "no_disease_modifying_therapy": "No FDA-approved treatments for FTD",
      "symptomatic_management": {
        "behavioral_symptoms": {
          "SSRIs": "Trazodone, sertraline for disinhibition, compulsive behaviors",
          "antipsychotics": "Low-dose quetiapine if needed; use cautiously",
          "avoid": "Cholinesterase inhibitors (may worsen behavior)"
        },
        "speech_therapy": "For language variants; augmentative communication devices",
        "occupational_therapy": "Structured routines, safety modifications"
      },
      "supportive_care": [
        "Caregiver education and support",
        "Behavioral management strategies",
        "Safety planning (driving, finances)",
        "Advance care planning early in disease"
      ],
      "genetic_counseling": "For patients with family history or confirmed mutations",
      "clinical_trials": "Encourage enrollment in FTD research trials"
    }
  },
  "skos": {
    "prefLabel": {
      "@language": "en",
      "@value": "Frontotemporal Dementia"
    },
    "altLabel": [
      {"@language": "en", "@value": "FTD"},
      {"@language": "en", "@value": "Frontotemporal lobar degeneration"},
      {"@language": "en", "@value": "Pick's disease"},
      {"@language": "en", "@value": "Behavioral variant FTD"}
    ],
    "definition": {
      "@language": "en",
      "@value": "A heterogeneous group of neurodegenerative disorders affecting frontal and temporal lobes, characterized by progressive changes in behavior, personality, and/or language"
    },
    "notation": "neuro-018",
    "scopeNote": {
      "@language": "en",
      "@value": "Covers clinical variants, pathology, genetics, and symptomatic management of FTD"
    }
  },
  "relationships": {
    "skos:broader": [
      {
        "@id": "wsmg:health-sciences/medicine/neurology/dementia-syndromes",
        "skos:prefLabel": "Dementia Syndromes"
      }
    ],
    "skos:narrower": [
      {
        "@id": "wsmg:health-sciences/medicine/neurology/behavioral-variant-ftd",
        "skos:prefLabel": "Behavioral Variant FTD"
      },
      {
        "@id": "wsmg:health-sciences/medicine/neurology/semantic-dementia",
        "skos:prefLabel": "Semantic Variant PPA"
      }
    ],
    "skos:related": [
      {
        "@id": "wsmg:health-sciences/medicine/neurology/neuro-015",
        "skos:prefLabel": "Alzheimer Disease"
      },
      {
        "@id": "wsmg:health-sciences/medicine/neurology/neuro-014",
        "skos:prefLabel": "Amyotrophic Lateral Sclerosis"
      }
    ],
    "owl:sameAs": [
      "http://dbpedia.org/resource/Frontotemporal_dementia"
    ]
  },
  "medicalCode": [
    {
      "@type": "MedicalCode",
      "codingSystem": "SNOMED-CT",
      "codeValue": "230270009",
      "uri": "http://snomed.info/id/230270009",
      "description": "Frontotemporal dementia"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "ICD-10-CM",
      "codeValue": "G31.09",
      "uri": "http://hl7.org/fhir/sid/icd-10-cm/G31.09",
      "description": "Other frontotemporal dementia"
    },
    {
      "@type": "MedicalCode",
      "codingSystem": "MeSH",
      "codeValue": "D057180",
      "uri": "http://id.nlm.nih.gov/mesh/D057180",
      "description": "Frontotemporal Dementia"
    }
  ],
  "pedagogical": {
    "learning_objectives": [
      "Distinguish frontotemporal dementia from Alzheimer's disease clinically",
      "Identify the three main clinical variants of FTD",
      "Recognize behavioral features diagnostic of bvFTD",
      "Understand the genetic basis of FTD including C9orf72 expansion",
      "Apply appropriate symptomatic management strategies"
    ],
    "clinical_pearls": [
      "Memory preserved early + personality change + younger onset = think FTD, not AD",
      "Disinhibition + apathy + compulsive eating = bvFTD triad",
      "C9orf72 expansion can cause both FTD and ALS - screen family for both",
      "Cholinesterase inhibitors may WORSEN behavioral symptoms in FTD",
      "SSRIs (especially trazodone) are first-line for behavioral management"
    ],
    "board_yield": "MEDIUM",
    "estimated_time": "25min",
    "target_audience": [
      "neurology_residents",
      "geriatric_medicine_fellows",
      "psychiatry_residents"
    ],
    "common_misconceptions": [
      "FTD is rare - it's the second most common early-onset dementia",
      "Memory loss is always first in dementia - behavior/language dominate in FTD",
      "FTD patients lack insight - some variants preserve insight early"
    ]
  },
  "prerequisites": [
    {
      "@id": "wsmg:health-sciences/medicine/neurology/dementia-evaluation",
      "skos:prefLabel": "Dementia Evaluation"
    }
  ],
  "related_concepts": [
    "dementia",
    "primary progressive aphasia",
    "ALS-FTD spectrum",
    "C9orf72"
  ],
  "evidence": {
    "citations": [
      {
        "authors": "Rascovsky K, Hodges JR, Knopman D, et al.",
        "title": "Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia",
        "journal": "Brain",
        "year": 2011,
        "volume": "134",
        "pages": "2456-2477",
        "doi": "10.1093/brain/awr179"
      }
    ],
    "confidence_rationale": "Based on international consensus diagnostic criteria for FTD"
  },
  "provenance": {
    "verification_status": "verified",
    "last_verified": "2026-01-13T14:42:00.000Z",
    "sources": [
      {
        "source": "Harrison's Principles of Internal Medicine, 21st ed.",
        "type": "textbook",
        "year": 2022,
        "isbn": "978-1264268504",
        "relevance": "Standard internal medicine reference"
      },
      {
        "source": "International bvFTD Criteria Consortium",
        "type": "clinical_guideline",
        "year": 2011,
        "relevance": "Consensus diagnostic criteria"
      }
    ]
  },
  "quality_assessment": {
    "content_quality_score": 0.94,
    "completeness": 0.95,
    "accuracy": 0.96,
    "clarity": 0.93,
    "clinical_relevance": 0.95,
    "last_assessed": "2026-01-13T14:42:00.000Z"
  },
  "owl:sameAs": "http://dbpedia.org/resource/Frontotemporal_dementia",
  "skos:exactMatch": "http://www.wikidata.org/entity/Q944519"
}